Hall, Helen
Ruparel, Mamta
Quaife, Samantha L.
Dickson, Jennifer L.
Horst, Carolyn
Tisi, Sophie
Batty, James
Woznitza, Nicholas
Ahmed, Asia
Burke, Stephen
Shaw, Penny
Soo, May Jan
Taylor, Magali
Navani, Neal
Bhowmik, Angshu
Baldwin, David R.
Duffy, Stephen W.
Devaraj, Anand
Nair, Arjun
Janes, Sam M. http://orcid.org/0000-0002-6634-5939
Funding for this research was provided by:
Cancer Research UK - National Awareness and Early Diagnosis Initiative project grant (164679)
Roy Castle Lung Cancer Foundation (166763)
Article History
Received: 18 January 2022
Revised: 11 March 2022
Accepted: 13 April 2022
First Online: 14 May 2022
Declarations
:
: The scientific guarantor of this publication is Professor Sam Janes.
: The authors of this manuscript declare relationships with the following companies: SJ is on the advisory board for Optellum, and AN is on the advisory board for Aidence BV and Faculty Science Ltd. The authors do not perceive an academic conflict with this study.
: Professor Stephen Duffy kindly provided statistical advice for this manuscript.
: Written informed consent was obtained from all subjects (patients) in this study.
: Institutional Review Board approval was obtained.
: Some study subjects or cohorts have been previously reported in previous publications: Data relating to the response to targeted LCS information materials (Quaife, AJRCCM, 2020) and lung cancer prevalence (Ruparel, Thorax, 2020) in this cohort have been published previously. Additionally, preliminary analyses from this paper were presented as a poster at the British Thoracic Conference 2019, with the abstract published (Hall, Thorax 2019). The full analysis of radiographer reporting presented in this manuscript has not been published elsewhere.
: • prospective• observational• multicenter study